GlassScriptPhysician profile
William Thomas Oakes
NPI 1205829330
$2,790.75
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,511 · 2020: $1,280.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $446.43 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $346.53 | 2019-2020 | |
| Emd Serono, INC. | $340.05 | 2019-2020 | |
| Lilly USA, LLC | $249.10 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $242.59 | 2019-2020 | |
| Amgen INC. | $137.54 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $112.24 | 2019 | |
| Greenwich Biosciences, INC. | $101.80 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $97.22 | 2019 | |
| Novartis Pharmaceuticals Corporation | $95.10 | 2019-2020 | |
| Sk Life Science, INC. | $91.58 | 2020 | |
| Mallinckrodt Enterprises LLC | $82.88 | 2019 | |
| Upsher-Smith Laboratories LLC | $79.03 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $70.66 | 2020 | |
| Harmony Biosciences LLC | $44.60 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $42.75 | 2019 | |
| Allergan, INC. | $38.49 | 2020 | |
| Neurelis, INC. | $30.93 | 2020 | |
| Supernus Pharmaceuticals, INC. | $29.76 | 2019 | |
| Tanabe Pharma America, INC. | $24.83 | 2020 | |
| Ucb, INC. | $22.09 | 2019 | |
| Acorda Therapeutics, INC | $20.86 | 2019 | |
| Piramal Critical Care | $18.80 | 2019 | |
| Genentech USA, INC. | $13.28 | 2019 | |
| Medtronic Vascular, INC. | $11.61 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Oakes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.